Skip to content
2000
Volume 5, Issue 4
  • ISSN: 1573-3963
  • E-ISSN: 1875-6336

Abstract

Epstein-Barr virus (EBV), one of the eight known human herpesviruses, generally infects subclinically. However, in certain circumstances, EBV causes overt diseases such as infectious mononucleosis (IM), usually a selflimiting disorder, by its primary infection. Additionally, it associates the development of various human malignancies including EBV genome-positive Burkitt's lymphoma (BL) and undifferentiated nasopharyngeal carcinoma (NPC). More recently, EBV infection has been thought to be etiologically linked to the occurrence of lymphoproliferative disease (LPD) in immunologically compromised individuals either with hereditary or secondary condition, and the other lifethreatening diseases such as hemophagocytic lymphohistiocytosis (HLH) and chronic active EBV infection (CAEBV). This review mainly introduces, focuses and discusses on the recent advances of EBV infection regarding its pathogenetic mechanism(s), diagnosis and treatment.

Loading

Article metrics loading...

/content/journals/cpr/10.2174/157339609791317324
2009-11-01
2025-09-09
Loading full text...

Full text loading...

/content/journals/cpr/10.2174/157339609791317324
Loading

  • Article Type:
    Research Article
Keyword(s): Epstein-Barr virus; herpesviruses; human diseases
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test